Inpatient monitoring and prognostic importance of B-type natriuretic peptide.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Congestive Heart Failure

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1751-7133.2008.TB00008.XPMID 18833664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study.

  2008cited by this paper
• B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.

  2008cited by this paper
• Prognostic role of B‐type natriuretic peptide in patients with diabetes and acute decompensated heart failure

  2007cited by this paper
• Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.

  2007cited by this paper
• Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure.

  2007cited by this paper
• Usefulness of Inhospital Change in B‐Type Natriuretic Peptide Levels in Predicting Long‐Term Outcome in Elderly Patients Admitted for Decompensated Heart Failure

  2007cited by this paper
• B-type natriuretic peptide predicts postdischarge prognosis in elderly patients admitted due to cardiogenic pulmonary edema.

  2006cited by this paper
• Heart failure observation units: optimizing care.

  2006cited by this paper
• NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

  2006cited by this paper
• 35 B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure: the BIC study

  2006cited by this paper
• Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

  2006cited by this paper
• Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

  2006cited by this paper
• 217 Low readmission rate of low B-type natriuretic peptide patients admitted for heart failure are not further reduced by an active cardiological follow-up

  2005cited by this paper
• How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

  2005cited by this paper
• B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.

  2005cited by this paper
• Heart failure care in a hospital unit: a comparison of standard 3‐month and extended 6‐month programs

  2005cited by this paper
• Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure.

  2004cited by this paper
• N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients

  2004cited by this paper
• Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

  2004cited by this paper
• Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.

  2004cited by this paper
• N‐terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF)

  2004cited by this paper
• Care Management for Low-Risk Patients with Heart Failure

  2004cited by this paper
• Optimal Noninvasive Assessment of Left Ventricular Filling Pressures: A Comparison of Tissue Doppler Echocardiography and B-Type Natriuretic Peptide in Patients With Pulmonary Artery Catheters

  2004cited by this paper
• Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

  2004cited by this paper
• The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

  2003cited by this paper
• The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.

  2003cited by this paper
• Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study.

  2003cited by this paper
• A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

  2001cited by this paper
• A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.

  2001cited by this paper
• Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

  2001cited by this paper
• N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.

  2000cited by this paper
• Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures: A Comparative Simultaneous Doppler-Catheterization Study

  2000cited by this paper
• BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria.

  1997cited by this paper

• Optimizing Post-Discharge Heart Failure Care: The Role of Natriuretic Peptides

  2025cites this paper
• Otimizando o Manuseio da Insuficiência Cardíaca após a Alta: O Papel dos Peptídeos Natriuréticos

  2025cites this paper
• Booster COVID-19 vaccine comirnaty ignite supraventricular tachycardia in Wolff Parkinson White Syndrome

  2022cites this paper
• N‐terminal pro BNP and galectin‐3 are prognostic biomarkers of acute heart failure in sub‐Saharan Africa: lessons from the BAHEF trial

  2020cites this paper
• Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug screening

  2019cites this paper
• Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing.

  2019cites this paper
• Role of β-type natriuretic peptide as predictor of early post-operative outcomes in Chinese patients undergoing anesthesia

  2017cites this paper
• Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure

  2017cites this paper
• Characteristics and outcomes of acute heart failure in sub Saharan Africa

  2016cites this paper
• The prognostic combined role of B-type natriuretic peptide, blood urea nitrogen and congestion signs persistence in patients with acute heart failure

  2016cites this paper
• [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].

  2016cites this paper
• Original Article Brain Natriuretic Peptide as the long-term cause of mortality in patients with cardiovascular disease: a retrospective cohort study

  2015cites this paper
• Brain Natriuretic Peptide as the long-term cause of mortality in patients with cardiovascular disease: a retrospective cohort study.

  2015cites this paper
• Status 2 patients had poor prognosis without mechanical circulatory support.

  2014cites this paper
• Tiroid Fonksiyon Bozukluğu Bulunan Hastalarda Erken Dönem Kardiyak Disfonksiyonu Belirlemede N-Terminal Pro-B-Tip Natriüretik Peptid N-Terminal Pro-B-Type Natriuretic Peptide For Detecting Early Cardiac Dysfunction in Patients with Thyroid Dysfunction

  2013cites this paper
• Physiology and clinical significance of natriuretic hormones

  2013cites this paper
• The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction

  2013cites this paper
• Can parathyroid hormone be used as a biomarker for heart failure?

  2013cites this paper
• Predictive value of B-type natriuretic peptide level on the postoperative course of infants with congenital heart disease.

  2013cites this paper
• Prognostic Value of Combining Echocardiography and Natriuretic Peptide Levels in Patients with Heart Failure

  2012cites this paper
• Natriuretic peptides and NGAL in heart failure: does a link exist?

  2012cites this paper
• B-type natriuretic peptide as a predictor of outcome in a general intensive care unit

  2011cites this paper
• Natriuretic peptides in heart failure: where we are, where we are going

  2011cites this paper
• Prognostic value of B-type natriuretic peptide in patients with left bundle-branch block admitted for acute heart failure.

  2011cites this paper